Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Denali Capital Acquisition Corp Class A ( (DNQAF) ) just unveiled an announcement.
Denali Capital Acquisition Corp. has amended its merger agreement with Semnur Pharmaceuticals, a subsidiary of Scilex Holding Company, to facilitate the issuance of additional shares of Semnur’s common stock before the completion of their business combination. This amendment, dated July 22, 2025, modifies the exchange ratio and merger consideration, potentially impacting the company’s operations and market positioning by allowing for private placement financing and issuance to advisors and service providers.
More about Denali Capital Acquisition Corp Class A
Average Trading Volume: 440
Technical Sentiment Signal: Hold
Current Market Cap: $30.19M
See more insights into DNQAF stock on TipRanks’ Stock Analysis page.